Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy-Reference-Cited by-同舟云学术

Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy

Published:2020-05-20 Issue:7 Volume:37 Page:3178-3184
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Canale Maria Laura,Camerini Andrea^ORCID,Casolo Giancarlo,Lilli Alessio,Bisceglia Irma,Parrini Iris,Lestuzzi Chiara,Del Meglio Jacopo,Puccetti Cheti,Camerini Lara,Amoroso Domenico,Maurea Nicola

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-020-01386-y.pdf

Reference20 articles.

1. Rotte A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer. J Exp Clin Cancer Res. 2019;38:255.

2. Ackermann CJ, Reck M, Paz-Ares L, Barlesi F, Califano R. First-line immune checkpoint blockade for advanced non-small-cell lung cancer: travelling at the speed of light. Lung Cancer. 2019;134:245–53.

3. Weiss SA, Wolchok JD, Sznol M. Immunotherapy of melanoma: facts and hopes. Clin Cancer Res. 2019;25:5191–201.

4. Chang AJ, Zhao L, Zhu Z, et al. The past, present and future of immunotherapy for metastatic renal cell carcinoma. Anticancer Res. 2019;39:2683–7.

5. Spain L, Walls G, Julve M, et al. Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature. Ann Oncol. 2017;28:377–85.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLA2G2D promotes immune escape in non‐small cell lung cancer by regulating T cell immune function through PD‐L1‐expressing extracellular vesicles;Scandinavian Journal of Immunology;2024-06-24

2. Immune Checkpoint Inhibitors and Cardiotoxicity: A Comparative Meta‐Analysis of Observational Studies and Randomized Controlled Trials;Journal of the American Heart Association;2024-05-21

3. Immune checkpoint inhibitors and pericardial disease: a systematic review;Cardio-Oncology;2024-05-17

4. A CASE OF STAGE IV NON-SMALL CELL LUNG CANCER MANAGEMENT IN THE MODERN ERA: HOW MUCH IS TOO MUCH?;CHEST;2023-10

5. Cardiothoracic complications of immune checkpoint inhibitors;Clinical Imaging;2023-10